Bioequivalence study of fixed dose combination of atorvastatin and ezetimibe tablet in healthy volunteers by LC-MS/MS method

Asian Journal of Chemistry

Volumn 19, Issue 2, 2007, Pages 1293-1300

  Gowda, K Veeran ^a   Rajan, D Senthil ^a   Mandal, U ^a   Solomon, W D Sam ^a   Selvan, P Senthamil ^a   Bose, A ^a   Sarkar, A K ^a   Chattarah, T K ^a,b   Pal, T K ^a  

^a JADAVPUR UNIVERSITY   (India)

^b NRS MEDICAL COLLEGE   (India)

Author keywords

Atorvastatin; Bioequivalence; Ezetimibe; Fixed dose combination; LC MS MS; Pharmacokinetics

Indexed keywords

EID: 33846986018     PISSN: 09707077     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. P. Cole and X. Rabasseda, Drugs Today (Bare.), 41, 317 (2005).
2. H. Bays and E.A. Stein, Exp. Opin. Pharmacother., 4, 1901 (2003).
3. K.F. Croom and GL. Plosker, Drugs, 65, 137 (2005).
4. M. Schachter, Fundam. Clin. Pharmacol., 19, 117 (2005).
5. S. Erturk, E. Sevinc Aktas, L. Ersoy and S. Ficicioglu, J. Pharm. Biomed. Anal., 33, 1017 (2003).
6. A. Zarghi, A. Shafaati, S.M. Foroulan and A. Khaddam, Arzneimittelforschung, 55, 451 (2005).
7. M. Hermann, H. Christensen and J.L. Reubaset, Anal. Bioanal. Chem., 382, 1242 (2005).
8. M. Jemal, Z. Ouyang, B.C. Chen and D. Tentz, Rapid Commun. Mass Spectrom., 13, 1003 (1999).
9. W.W. Bullen, R.A. Miller and R.N. Hayes, J. Am. Soc. Mass Spectrom., 10, 66 (1999).
10. L. Reyderman, T. Kosoglou, P. Statkevich, L. Pember, T. Boutros, S.E. Maxwell, M. Affrime and V. Batra, Int. J. Clin. Pharmacol. Ther., 42, 512 (2004).
11. M. Farnier, Int. J. Clin. Pract., 56, 611 (2002).
12. J. Ducobu and J. Sternon, Rev. Med. Brux., 25, 451 (2004).
13. F. Ezzet, G. Krishna, D.B. Wexler, P. Statkevich, Clin Therm., 23, 871 (2001).
14. T. Kosoglou, P. Statkevich, A.O. Johnson, J.F. Paolini, A.J. Bergman, Clin. Pharmacokinet., 44, 467 (2005).
15. C. Simard and J. Turgeon, Can. J. Clin. Pharmacol., 10A, 20 (2003).
16. R. Sistla, V.S. Tata, Y.V. Kashyap, D. Chandrasekar and P.V. Diwan, J. Pharm. Biomed. Anal., 39, 517 (2005).
17. S. Oswald, E. Scheuch, I. Cascorbi and W. Siegmund, J. Chromatogr. B. Analyt. Biomed. Life Sci., 830, 143 (2005).
18. US Food and Drug Administration, Centre for Drug Evaluation and Research Guidance: Bioavailability and Bioequivalence Studies for Orally Administered Drug Products - General Considerations, October (2000).
19. Committee for Proprietary Medicinal Products: Working party on the Efficacy of the Medicinal Products, Note for guidance: Investigation of Bioavailability and Bioequivalence (1991).
20. R.L. Nation and L.N. Sansom, Pharmacol. Ther., 62, 41 (1994).
21. W. A. Ritschel, in: Handbook of Basic Pharmacokinetics, Drug Intelligence, Hamilton, edn. 4, p. 588 (1992).